Bovine spongiform encephalopathy infection alters endogenous retrovirus expression in distinct brain regions of cynomolgus macaques (Macaca fascicularis)

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Greenwood, Alex D ^a   Vincendeau, Michelle ^b   Schmädicke, Ann Christin ^c   Montag, Judith ^c,e   Seifarth, Wolfgang ^d   Motzkus, Dirk ^c  

^a LEIBNIZ INSTITUTE FOR ZOO AND WILDLIFE RESEARCH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c GERMAN PRIMATE CENTER   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN REGION; BRAIN STEM; CEREBELLUM VERMIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FRONTAL CORTEX; MACACA FASCICULARIS; MOUSE; NERVE DEGENERATION; NONHUMAN; PARIETAL CORTEX; PRION DISEASE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS INFECTION;

ANIMALIA; BOS; BOVINAE; MACACA; MACACA FASCICULARIS; MURINAE; PRIMATES;

EID: 79959419232     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-44     Document Type: Article

References (76)

1. Introduction to the transmissible spongiform encephalopathies or prion diseases. B Chesebro, British medical bulletin 2003 66 1 20 10.1093/bmb/66.1.1 14522845 (Pubitemid 37173488)
2. Prion diseases: from molecular biology to intervention strategies. M Nunziante, S Gilch, HM Schatzl, Chembiochem 2003 4 1268 1284 10.1002/cbic.200300704 14661267 (Pubitemid 38036407)
3. Mammalian prion biology: one century of evolving concepts. A Aguzzi, M Polymenidou, Cell 2004 116 313 327 10.1016/S0092-8674(03)01031-6 14744440 (Pubitemid 38167320)
4. Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies. SA Priola, I Vorberg, Methods in molecular biology (Clifton, NJ 2004 268 517 540
5. Molecular biology of prion diseases. SB Prusiner, Science (New York, NY 1991 252 1515 1522 10.1126/science.1675487 (Pubitemid 21917065)
6. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. KM Pan, M Baldwin, J Nguyen, M Gasset, A Serban, D Groth, I Mehlhorn, Z Huang, RJ Fletterick, FE Cohen, et al. Proceedings of the National Academy of Sciences of the USA 1993 90 10962 10966 10.1073/pnas.90.23. 10962 7902575 (Pubitemid 23354348)
7. Prions and their partners in crime. B Caughey, GS Baron, Nature 2006 443 803 810 10.1038/nature05294 17051207 (Pubitemid 44622685)
8. Evidence for protein × binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. K Kaneko, L Zulianello, M Scott, CM Cooper, AC Wallace, TL James, FE Cohen, SB Prusiner, Proceedings of the National Academy of Sciences of the USA 1997 94 10069 10074 10.1073/pnas.94.19.10069 9294164 (Pubitemid 27406995)
9. The possible role of protein X, a putative auxiliary factor in pathological prion replication, in regulating a physiological endoproteolytic cleavage of cellular prion protein. NS Hachiya, M Imagawa, K Kaneko, Medical hypotheses 2007 68 670 673 10.1016/j.mehy.2006.07.038 17008028 (Pubitemid 46037956)
10. The dominant-negative effect of the Q218K variant of the prion protein does not require protein X. CI Lee, Q Yang, V Perrier, IV Baskakov, Protein Sci 2007 16 2166 2173 10.1110/ps.072954607 17766375 (Pubitemid 47481651)
11. Identification of differentially expressed genes in scrapie-infected mouse neuroblastoma cells. K Doh-ura, S Perryman, R Race, B Chesebro, Microbial pathogenesis 1995 18 1 9 7783594
12. Identification of upregulated genes in scrapie-infected brain tissue. C Riemer, I Queck, D Simon, R Kurth, M Baier, Journal of virology 2000 74 10245 10248 10.1128/JVI.74.21.10245-10248.2000 11024157
13. Gene expression profiling of scrapie-infected brain tissue. C Riemer, S Neidhold, M Burwinkel, A Schwarz, J Schultz, J Kratzschmar, U Monning, M Baier, Biochemical and biophysical research communications 2004 323 556 564 10.1016/j.bbrc.2004.08.124 15369787 (Pubitemid 39221133)
14. Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. CA Baker, L Manuelidis, Proceedings of the National Academy of Sciences of the USA 2003 100 675 679 10.1073/pnas.0237313100 12525699 (Pubitemid 36126111)
15. Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. W Xiang, O Windl, G Wunsch, M Dugas, A Kohlmann, N Dierkes, IM Westner, HA Kretzschmar, Journal of virology 2004 78 11051 11060 10.1128/JVI.78.20.11051-11060.2004 15452225 (Pubitemid 39299645)
16. Gene expression profiling of the preclinical scrapie-infected hippocampus. AR Brown, S Rebus, CS McKimmie, K Robertson, A Williams, JK Fazakerley, Biochemical and biophysical research communications 2005 334 86 95 10.1016/j.bbrc.2005.06.060 15992767 (Pubitemid 40978510)
17. Cell line dependent RNA expression profiles of prion-infected mouse neuronal cells. AD Greenwood, M Horsch, A Stengel, I Vorberg, G Lutzny, E Maas, S Schadler, V Erfle, J Beckers, H Schatzl, C Leib-Mosch, Journal of molecular biology 2005 349 487 500 10.1016/j.jmb.2005.03.076 15896347 (Pubitemid 40724560)
18. Molecular analysis of bovine spongiform encephalopathy infection by cDNA arrays. GP Sawiris, KG Becker, EJ Elliott, R Moulden, RG Rohwer, The Journal of general virology 2007 88 1356 1362 10.1099/vir.0.82387-0 17374782 (Pubitemid 46523527)
19. Identification of genes differentially expressed in SH-SY5Y neuroblastoma cells exposed to the prion peptide 106-126. T Martinez, A Pascual, The European journal of neuroscience 2007 26 51 59 10.1111/j.1460-9568.2007.05646.x 17596192 (Pubitemid 47035451)
20. Prion-induced activation of cholesterogenic gene expression by Srebp2 in neuronal cells. C Bach, S Gilch, R Rost, AD Greenwood, M Horsch, GN Hajj, S Brodesser, A Facius, S Schadler, K Sandhoff, et al. The Journal of biological chemistry 2009 284 31260 31269 10.1074/jbc.M109.004382 19748890
21. Gene expression profiling to identify druggable targets in prion diseases. F Benetti, L Gasperini, M Zampieri, G Legname, Expert Opinion on Drug Discovery 2010 5 177 202 10.1517/17460440903544449
22. Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease. J Montag, R Hitt, L Opitz, WJ Schulz-Schaeffer, G Hunsmann, D Motzkus, Molecular neurodegeneration 2009 4 36 10.1186/1750-1326-4-36 19712440
23. Transcriptional stability of cultured cells upon prion infection. C Julius, G Hutter, U Wagner, H Seeger, V Kana, J Kranich, PC Klohn, C Weissmann, G Miele, A Aguzzi, Journal of molecular biology 2008 375 1222 1233 10.1016/j.jmb.2007.11.003 18082765
24. Scrapie strain-specific interactions with endogenous murine leukaemia virus. RI Carp, HC Meeker, V Caruso, E Sersen, The Journal of general virology 1999 80 Pt 1 5 10 9934676 (Pubitemid 29041672)
25. Prion infection influences murine endogenous retrovirus expression in neuronal cells. A Stengel, C Bach, I Vorberg, O Frank, S Gilch, G Lutzny, W Seifarth, V Erfle, E Maas, H Schatzl, et al. Biochemical and biophysical research communications 2006 343 825 831 10.1016/j.bbrc.2006.03.021 16564028
26. Retrovirus infection strongly enhances scrapie infectivity release in cell culture. P Leblanc, S Alais, I Porto-Carreiro, S Lehmann, J Grassi, G Raposo, JL Darlix, The EMBO journal 2006 25 2674 2685 10.1038/sj.emboj.7601162 16724107 (Pubitemid 43980376)
27. Scrapie infection activates the replication of ecotropic, xenotropic, and polytropic murine leukemia virus (MuLV) in brains and spinal cords of senescence-accelerated mice: implication of MuLV in progression of scrapie pathogenesis. KH Lee, BH Jeong, JK Jin, HC Meeker, JI Kim, RI Carp, YS Kim, Biochemical and biophysical research communications 2006 349 122 130 10.1016/j.bbrc.2006.08.016 16930537 (Pubitemid 44331771)
28. The prevalence of human endogenous retroviruses in cerebrospinal fluids from patients with sporadic Creutzfeldt-Jakob disease. BH Jeong, YJ Lee, RI Carp, YS Kim, J Clin Virol 2010 47 136 142 10.1016/j.jcv.2009.11.016 20005155
29. Endogenous Retroviruses. J Denner, Retroviruses: Molecular Biology, Genomics and Pathogenesis Hethersett, Norwich, UK: Caister Academic Press, Kurth R, Bannert N, 2010 35 69
30. Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution. S Blaise, N de Parseval, L Benit, T Heidmann, Proceedings of the National Academy of Sciences of the USA 2003 100 13013 13018 10.1073/pnas.2132646100 14557543 (Pubitemid 37340017)
31. Syncytin-A and syncytin-B, two fusogenic placenta-specific murine envelope genes of retroviral origin conserved in Muridae. A Dupressoir, G Marceau, C Vernochet, L Benit, C Kanellopoulos, V Sapin, T Heidmann, Proceedings of the National Academy of Sciences of the USA 2005 102 725 730 10.1073/pnas.0406509102 15644441 (Pubitemid 40282733)
32. Functional characterization of syncytin-A, a newly murine endogenous virus envelope protein. X Peng, J Pan, R Gong, Y Liu, S Kang, H Feng, G Qiu, D Guo, P Tien, G Xiao, Implication for its fusion mechanism. The Journal of biological chemistry 2007 282 381 389 (Pubitemid 47076603)
33. Identification of an endogenous retroviral envelope gene with fusogenic activity and placenta-specific expression in the rabbit: a new "syncytin" in a third order of mammals. O Heidmann, C Vernochet, A Dupressoir, T Heidmann, Retrovirology 2009 6 107 10.1186/1742-4690-6-107 19943933
34. Induced prion protein controls immune-activated retroviruses in the mouse spleen. M Lotscher, M Recher, KS Lang, A Navarini, L Hunziker, R Santimaria, M Glatzel, P Schwarz, J Boni, RM Zinkernagel, PloS one 2007 2 1158 10.1371/journal.pone.0001158 17987132 (Pubitemid 351597633)
35. Identification of point mutations in the envelope gene of Moloney murine leukemia virus TB temperature-sensitive paralytogenic mutant ts1: molecular determinants for neurovirulence. PF Szurek, PH Yuen, R Jerzy, PK Wong, Journal of virology 1988 62 357 360 3334748 (Pubitemid 18050825)
36. The prion protein gene is dispensable for the development of spongiform myeloencephalopathy induced by the neurovirulent Cas-Br-E murine leukemia virus. P Jolicoeur, G Masse, DG Kay, Journal of virology 1996 70 9031 9034 8971038 (Pubitemid 26378493)
37. 10A1-MuLV but not the related amphotropic 4070A MuLV is highly neurovirulent: importance of sequences upstream of the structural Gag coding region. C Munk, V Prassolov, M Rodenburg, V Kalinin, J Lohler, C Stocking, Virology 2003 313 44 55 10.1016/S0042-6822(03)00210-1 12951020 (Pubitemid 37013594)
38. Risk of oral infection with bovine spongiform encephalopathy agent in primates. CI Lasmezas, E Comoy, S Hawkins, C Herzog, F Mouthon, T Konold, F Auvre, E Correia, N Lescoutra-Etchegaray, N Sales, et al. Lancet 2005 365 781 783 15733719 (Pubitemid 40311365)
39. The distribution of pol containing human endogenous retroviruses in non-human primates. AD Greenwood, A Stengel, V Erfle, W Seifarth, C Leib-Mosch, Virology 2005 334 203 213 10.1016/j.virol.2005.01.045 15780870 (Pubitemid 40386954)
40. Expression profiles of endogenous retroviruses in Old World monkeys. A Stengel, C Roos, G Hunsmann, W Seifarth, C Leib-Mosch, AD Greenwood, Journal of virology 2006 80 4415 4421 10.1128/JVI.80.9.4415-4421.2006 16611901
41. Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus-specific microarray. W Seifarth, O Frank, U Zeilfelder, B Spiess, AD Greenwood, R Hehlmann, C Leib-Mosch, Journal of virology 2005 79 341 352 10.1128/JVI.79.1.341-352.2005 15596828 (Pubitemid 39648388)
42. Assessment of retroviral activity using a universal retrovirus chip. W Seifarth, B Spiess, U Zeilfelder, C Speth, R Hehlmann, C Leib-Mosch, Journal of virological methods 2003 112 79 91 10.1016/S0166-0934(03)00194-0 12951215 (Pubitemid 37338261)
43. Guideline to reference gene selection for quantitative real-time PCR. A Radonic, S Thulke, IM Mackay, O Landt, W Siegert, A Nitsche, Biochemical and biophysical research communications 2004 313 856 862 10.1016/j.bbrc.2003.11.177 14706621 (Pubitemid 38050071)
44. A new mathematical model for relative quantification in real-time RT-PCR. MW Pfaffl, Nucleic acids research 2001 29 45 10.1093/nar/29.9.e45 11328886
45. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas. M Sauter, S Schommer, E Kremmer, K Remberger, G Dolken, I Lemm, M Buck, B Best, D Neumann-Haefelin, N Mueller-Lantzsch, Journal of virology 1995 69 414 421 7983737 (Pubitemid 24378819)
46. Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders. O Frank, M Giehl, C Zheng, R Hehlmann, C Leib-Mosch, W Seifarth, Journal of virology 2005 79 10890 10901 10.1128/JVI.79.17.10890-10901.2005 16103141 (Pubitemid 41170631)
47. Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours. N Gotzinger, M Sauter, K Roemer, N Mueller-Lantzsch, The Journal of general virology 1996 77 Pt 12 2983 2990 9000088 (Pubitemid 27058683)
48. Implication of human endogenous retroviruses in the development of autoimmune diseases. E Balada, M Vilardell-Tarres, J Ordi-Ros, International reviews of immunology 2010 29 351 370 10.3109/08830185.2010.485333 20635879
49. HERVs in neuropathogenesis. T Christensen, J Neuroimmune Pharmacol 2010 5 326 335 10.1007/s11481-010-9214-y 20422298
50. Beneficial and detrimental effects of human endogenous retroviruses. R Kurth, N Bannert, International journal of cancer 2010 126 306 314 10.1002/ijc.24902
51. Endogenous retroviruses and cancer. K Ruprecht, J Mayer, M Sauter, K Roemer, N Mueller-Lantzsch, Cell Mol Life Sci 2008 65 3366 3382 10.1007/s00018-008-8496-1 18818873
52. Development of broadly targeted human endogenous gammaretroviral pol-based real time PCRs Quantitation of RNA expression in human tissues. A Forsman, Z Yun, L Hu, D Uzhameckis, P Jern, J Blomberg, Journal of virological methods 2005 129 16 30 10.1016/j.jviromet.2005.04.016 15967513 (Pubitemid 41224768)
53. Oligodendrocytes are a major target of the toxicity of spongiogenic murine retroviruses. AC Clase, DE Dimcheff, C Favara, D Dorward, FJ McAtee, LE Parrie, D Ron, JL Portis, The American journal of pathology 2006 169 1026 1038 10.2353/ajpath.2006.051357 16936275 (Pubitemid 44411964)
54. The Opitz syndrome gene Mid1 is transcribed from a human endogenous retroviral promoter. JR Landry, A Rouhi, P Medstrand, DL Mager, Molecular biology and evolution 2002 19 1934 1942 12411602 (Pubitemid 35388116)
55. Lack of Mid1, the mouse ortholog of the Opitz syndrome gene, causes abnormal development of the anterior cerebellar vermis. A Lancioni, M Pizzo, B Fontanella, R Ferrentino, LM Napolitano, E De Leonibus, G Meroni, J Neurosci 2010 30 2880 2887 10.1523/JNEUROSCI.4196-09.2010 20181585
56. Functional characterization of the Opitz syndrome gene product (midin): evidence for homodimerization and association with microtubules throughout the cell cycle. S Cainarca, S Messali, A Ballabio, G Meroni, Human molecular genetics 1999 8 1387 1396 10.1093/hmg/8.8.1387 10400985 (Pubitemid 29374071)
57. The Opitz syndrome gene product, MID1, associates with microtubules. S Schweiger, J Foerster, T Lehmann, V Suckow, YA Muller, G Walter, T Davies, H Porter, H van Bokhoven, PW Lunt, et al. Proceedings of the National Academy of Sciences of the USA 1999 96 2794 2799 10.1073/pnas.96.6.2794 10077590 (Pubitemid 29148797)
58. Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles. L Manuelidis, ZX Yu, N Barquero, B Mullins, Proceedings of the National Academy of Sciences of the USA 2007 104 1965 1970 10.1073/pnas.0610999104 17267596 (Pubitemid 46239887)
59. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies. L Manuelidis, Journal of cellular biochemistry 2007 100 897 915 10.1002/jcb.21090 17044041
60. Focus on the antiviral properties of the cellular prion protein PrPC/CD230. S Alais, G Georges, C Berlioz-Torrent, P Leblanc, Prion 2010 4 187
61. Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. SM Campbell, SM Crowe, J Mak, J Clin Virol 2001 22 217 227 10.1016/S1386- 6532(01)00193-7 11564586 (Pubitemid 32846552)
62. Analysis of the interactions between HIV-1 and the cellular prion protein in a human cell line. P Leblanc, D Baas, JL Darlix, Journal of molecular biology 2004 337 1035 1051 10.1016/j.jmb.2004.02.007 15033368 (Pubitemid 38368942)
63. Cell-based quantification of chronic wasting disease prions. J Bian, D Napier, V Khaychuck, R Angers, C Graham, G Telling, Journal of virology 2010 84 8322 8326 10.1128/JVI.00633-10 20519392
64. Cells release prions in association with exosomes. B Fevrier, D Vilette, F Archer, D Loew, W Faigle, M Vidal, H Laude, G Raposo, Proceedings of the National Academy of Sciences of the USA 2004 101 9683 9688 10.1073/pnas. 0308413101 15210972 (Pubitemid 38869296)
65. A recombinant endogenous retrovirus amplified in a mouse neuroblastoma is involved in tumor growth in vivo. J Pothlichet, T Heidmann, M Mangeney, International journal of cancer 2006 119 815 822 10.1002/ijc.21935 (Pubitemid 44051444)
66. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles. S Alais, S Simoes, D Baas, S Lehmann, G Raposo, JL Darlix, P Leblanc, Biology of the cell/under the auspices of the European Cell Biology Organization 2008 100 603 615 18422484
67. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent. PK Nandi, JC Nicole, Journal of molecular biology 2004 344 827 837 10.1016/j.jmb.2004.09.080 15533448 (Pubitemid 39469223)
68. RNA molecules stimulate prion protein conversion. NR Deleault, RW Lucassen, S Supattapone, Nature 2003 425 717 720 10.1038/nature01979 14562104 (Pubitemid 37314314)
69. The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. C Gabus, S Auxilien, C Pechoux, D Dormont, W Swietnicki, M Morillas, W Surewicz, P Nandi, JL Darlix, Journal of molecular biology 2001 307 1011 1021 10.1006/jmbi.2001.4544 11286552 (Pubitemid 33031273)
70. The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. C Gabus, E Derrington, P Leblanc, J Chnaiderman, D Dormont, W Swietnicki, M Morillas, WK Surewicz, D Marc, P Nandi, JL Darlix, The Journal of biological chemistry 2001 276 19301 19309 10.1074/jbc.M009754200 11278562
71. Retroelements and the human genome: new perspectives on an old relation. N Bannert, R Kurth, Proceedings of the National Academy of Sciences of the USA 2004 101 Suppl 2 14572 14579 15310846 (Pubitemid 39346726)
72. Endogenous D-type (HERV-K) related sequences are packaged into retroviral particles in the placenta and possess open reading frames for reverse transcriptase. GR Simpson, C Patience, R Lower, RR Tonjes, HD Moore, RA Weiss, MT Boyd, Virology 1996 222 451 456 10.1006/viro.1996.0443 8806530 (Pubitemid 26279191)
73. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. K Bieda, A Hoffmann, K Boller, The Journal of general virology 2001 82 591 596 11172100 (Pubitemid 32177902)
74. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. K Boller, H Konig, M Sauter, N Mueller-Lantzsch, R Lower, J Lower, R Kurth, Virology 1993 196 349 353 10.1006/viro.1993.1487 8356806
75. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. R Contreras-Galindo, MH Kaplan, DM Markovitz, E Lorenzo, Y Yamamura, AIDS research and human retroviruses 2006 22 979 984 10.1089/aid.2006.22.979 17067267 (Pubitemid 46100682)
76. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. R Contreras-Galindo, MH Kaplan, P Leissner, T Verjat, I Ferlenghi, F Bagnoli, F Giusti, MH Dosik, DF Hayes, SD Gitlin, DM Markovitz, Journal of virology 2008 82 9329 9336 10.1128/JVI.00646-08 18632860